Posted by Michael Wonder on 08 May 2021
UK medicines regulator issues its first authorisation under Project Orbis
7 May 2021 - UK medicines regulator issues its first authorisation under Project Orbis for osimertinib (Tagrisso), a post-surgery treatment for lung cancer.
A post-surgery treatment for lung cancer will be the first to receive an authorisation from the Medicines and Healthcare products Regulatory Agency under Project Orbis - only four months after the agency joined the scheme in January 2021.
